药物对比
Eptinezumab vs Zolmitriptan
比较用于预防的CGRP单克隆抗体 Eptinezumab (Vyepti) 与用于急性偏头痛的曲普坦类药物 Zolmitriptan (Zomig)。了解用途、机制和适用性。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating migraine prevention with CGRP inhibitors versus acute triptan therapy or considering combination use for frequent attacks.
结论
Eptinezumab and Zolmitriptan address different migraine aspects—prevention versus acute treatment—so neither is inherently better and they may complement each other.
全部药物对比